Orphan designation: octreotide hydrochloride Treatment of acromegaly, 12/06/2009 Positive
At the time of designation, acromegaly affected approximately 1.2 in 10,000 people in the European Union (EU). This was equivalent to a total of around 61,000 people*, and is below the ceiling for orphan designation, which is 5 people in 10,000. This …